Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Adicet Bio, Inc. ACET

Set alert

Price alert · ACET

All alert types
3.31 USD +0.10 +3.28%

As of Nov 3, 11:54 AM ET

Bid
3.27 × 2
Ask
3.34 × 1
3.20 Day range 3.34
3.18 52-week range 11.82
YTD
-60.75%
1 year
-71.70%
Open
3.20
Prev close
3.20
Mkt cap
30.94M
Vol
9.30K
Avg vol
200.57K
EPS
-10.42
P/E
0.00
Div yield
0.00%
More statistics
Low
3.20
High
3.34
Forward P/E
-0.69
Beta
1.70
Short ratio
7.04
Inst. own
76.44%
Dividend
0.00
Ex-div date
50-d avg
1.16
200-d avg
1.48
1y target
6.40

1D chart

Chart tools
Interval
1m5m15m30m

Signals (24)
NameTimeAgo
MACD: Buy Signal4:00 PM3 days ago
MACD: Sell Signal3:54 PM3 days ago
SMA: Bullish3:39 PM3 days ago
SMA: Bullish3:39 PM3 days ago
MACD: Buy Signal3:04 PM3 days ago
SMA: Bearish2:16 PM3 days ago
SMA: Bearish2:16 PM3 days ago
SMA: Bullish2:06 PM3 days ago
SMA: Bullish2:06 PM3 days ago
MACD: Sell Signal2:01 PM3 days ago
SMA: Bearish1:57 PM3 days ago
SMA: Bearish1:57 PM3 days ago
SMA: Bullish1:48 PM3 days ago
SMA: Bullish1:48 PM3 days ago
SMA: Bearish1:33 PM3 days ago
SMA: Bearish1:33 PM3 days ago
SMA: Bullish12:29 PM4 days ago
SMA: Bullish12:29 PM4 days ago
SMA: Bearish12:19 PM4 days ago
MACD: Buy Signal12:01 PM4 days ago

Newest 20 of 24.

Analyst view

Consensus: buy

Buy
Price target (mean) 6.40 +93.6% upside
Target (low)
4.00
Target (mean)
6.40
Target (high)
8.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 8
  • 3 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ACET analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.355-0.37 – -0.35-0.69+48.5%00.0%4
Next quarter-0.365-0.37 – -0.36-0.35-4.3%00.0%2
Current year-1.34-1.39 – -1.23-3.31+59.4%00.0%6
Next year-1.30-1.56 – -0.91-1.34+2.9%2.50M0.0%7

Upgrades and downgrades

The latest rating changes

ACET analyst upgrades and downgrades
DateFirmActionFromTo
Dec 19, 2024HC Wainwright & Co.ReiteratedNeutralNeutral
Nov 18, 2024HC Wainwright & Co.Reiterated—Neutral
Aug 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 14, 2024Canaccord GenuityMaintainedBuyBuy
Jul 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 5, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 23, 2024WedbushReiteratedOutperformOutperform
Apr 2, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 20, 2024WedbushReiteratedOutperformOutperform
Mar 20, 2024Canaccord GenuityReiteratedBuyBuy
Feb 2, 2024HC Wainwright & Co.MaintainedBuyBuy
Jan 5, 2024Canaccord GenuityMaintainedBuyBuy
Nov 9, 2023WedbushMaintainedOutperformOutperform
Sep 6, 2023Truist SecuritiesReiteratedBuyBuy
Aug 11, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 10, 2023BTIGMaintainedBuyBuy
Aug 10, 2023WedbushReiteratedOutperformOutperform
Jun 27, 2023GuggenheimDowngradeBuyNeutral
Jun 27, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 27, 2023JMP SecuritiesDowngradeMarket OutperformMarket Perform
Jun 1, 2023JP MorganDowngradeOverweightNeutral
May 15, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
May 10, 2023WedbushReiterated—Outperform
May 10, 2023HC Wainwright & Co.Maintained—Buy
Mar 16, 2023WedbushReiterated—Outperform
Mar 16, 2023HC Wainwright & Co.Reiterated—Buy
Dec 12, 2022HC Wainwright & Co.Maintained—Buy